• Profile

Nonthyroidal illness syndrome in acute pancreatitis patients: An 8-year cohort study

BMC Gastroenterology Feb 05, 2022

Acute pancreatitis (AP) patients commonly develop nonthyroidal illness syndrome (NTIS) within 7 days after disease onset. NTIS was found to be linked with worse characteristics at admission and poor outcome during the course. Free triiodothyronine (FT3) merits exploration as a potential biomarker in the prediction of death in AP cases.

  • This retrospective review of AP patients with a diagnosis of NTIS from Jan 2012 to September 2020 was conducted to determine the prevalence, characteristics, and prognosis of NTIS and its correlation with outcomes in AP patients.

  • During a period of 8 years, NTIS diagnosis was made in 183 included AP patients, representing an incidence of 64.7%.

  • Relative to euthyroid patients, NTIS patients were admitted with worse condition based on the higher Acute physiology and chronic health evaluation II score, Sequential organ failure assessment score, Balthazar's CT score, C-reactive protein and lower albumin.

  • A longer ICU duration and more probability of developing infected pancreatic necrosis (15.3% vs 6.3%) and gastrointestinal fistula (6% vs 0%) were noted in NTIS patients vs euthyroid patients.

  • For predicting death, the performance of FT3 was the best, vs other well-recognized biomarkers.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
M3 app logo
Choose easy access to M3 India from your mobile!

M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen